BIODANE PHARMA A/S — Credit Rating and Financial Key Figures

BIODANE PHARMA A/S (CVR number: 28310102) is a company from VEJEN. The company recorded a gross profit of 3070.7 kDKK in 2023. The operating profit was 878.9 kDKK, while net earnings were 900.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 24.4 %, which can be considered excellent and Return on Equity (ROE) was 22 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 82.7 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. BIODANE PHARMA A/S's liquidity measured by quick ratio was 5.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.